Multi-Industry Comments on the Voluntary Disclosure of Sesame as an Allergen
ASTA signed onto industry coalition comments to the Food and Drug Administration (FDA) in February 2021 regarding the FDA's draft guidance titled Voluntary Disclosure of Sesame as an Allergen.
02/25/2021 at 5:15 am
1
Related Resources
Multi-Industry Comments on FDA's Tool for the Prioritization of Food Chemicals for Post-Market Assessment
In August 2025, ASTA signed onto comments written by the Food & Beverage Issue Alliance (FBIA) encouraging FDA to leverage a science-driven, iterative approach for the prioritization of chemicals for post-market assessments. The comments call for FDA to place greater weight on public health risk-related factors, differentiate prioritization and assessment frameworks between intentionally added substances and contaminants, and to enhance transparency and stakeholder engagement opportunities.
ASTA Letter to 2012 House Agriculture Appropriations
ASTA issued comments to the U.S. House of Representatives in November 2011 requesting that the House accept the Senate's higher amount of FY12 funding for the Food and Drug Administration in the FY 2012 Agriculture Appropriations budget.
